Peng Zhang
Capital Medical University(CN)Wuhan University(CN)Wuhan College(CN)Beijing Anzhen Hospital(CN)Shaoxing People's Hospital(CN)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, COVID-19 Clinical Research Studies, Signaling Pathways in Disease, SARS-CoV-2 and COVID-19 Research, COVID-19 and healthcare impacts
Most-Cited Works
- → Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis(2020)2,176 cited
- → Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes(2020)1,643 cited
- → Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19(2020)1,181 cited
- → Epidemiological Features of NAFLD From 1999 to 2018 in China(2020)666 cited
- → Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis(2019)593 cited
- → In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19(2020)498 cited